Sygnis AG, which makes products for DNA amplification and sequencing, has raised €5.6 million in a private equity placement while strengthening its balance sheet with a debt-for-equity swap with its major shareholder Genetrix SL of Spain. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
